AI-generated summary
The authors report a randomized, placebo-controlled trial of photobiomodulation combined with a static magnetic field in 30 severe COVID-19 patients on invasive mechanical ventilation. They found no significant difference in ICU length of stay between groups, but reported significant associations with diaphragm thickness, several ventilatory parameters, C-reactive protein and lymphocyte count.
- Participants
- 30
- Who or what was studied
- Severe COVID-19 adults in intensive care requiring invasive mechanical ventilation
- Limits stated in the abstract
- The abstract describes a small sample of 30 patients and reports the primary outcome as nonsignificant, so the secondary findings should be interpreted cautiously.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on dovepress.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Placebo-controlled, Trial registration, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.